Digital Health Coffee Time Briefing âÂ
Today’s briefing covers trials into the use of psychoactive medicines to treat PTSD and academics calling for regulation of Femtech devices.
Back to Top
Today’s briefing covers trials into the use of psychoactive medicines to treat PTSD and academics calling for regulation of Femtech devices.
Applications have opened for the Evidence Generator Bootcamp from DigitalHealth.London, aimed at companies looking to enhance their evidence generation.
Alcidion has launched Miya Results Tracking in a bid to reduce the risk of test results not being followed up and thus improve patient safety.
Our latest Movers and Shakers roundup features plenty of movement within NHS England and a new chief executive for Health Innovation Kent Surrey Sussex.
Health leaders have given a cautious welcome to the Spring budget’s announcement of ÂŁ3.4 billion of investment in NHS digitisation.
Today’s briefing includes NHS England publishing guidance on network segmentation and Sonari Analytics and Candel Therapeutics announcing a partnership.
Access HSC managing director Steve Sawyer has said that it is âblinkeredâ to solely look at and worry about EPRs because âit is not about the EPR anymoreâ.
The Universal Care Plan (UCP), OneLondonâs shared care planning solution, has extended to support sickle
A “deployment blockage” in the NHS is preventing AI from being adopted at scale, according
The Maritime and Coastguard Agency has launched a ÂŁ175 million search and rescue radio network
Imperial College Healthcare NHS Trustâs neurosurgery team has introduced mixed reality technology to improve training
Pancreatic Cancer UK has launched an online tool for families who have lost a loved